Seattle Children’s Opens World-Class Outpatient Facility for Patients with Cancer and Blood Disorders
An innovative new outpatient space for the Cancer and Blood Disorders Center (CBDC) and Pediatric Blood and Marrow Transplant (BMT) Program officially opened this week on two floors of Seattle Children’s newest building called Forest B. It nearly doubles CBDC’s clinical outpatient capacity to help Seattle Children’s meet the growing need for pediatric services in the region.The physical and operational design of the new space reflects Seattle Children’s commitment to a patient care model that brings complex care teams together in a single location, with the patient at the center.
“Our model of care sets us apart from any other program in the country,” said Dr. Mignon Loh, division chief of Pediatric Hematology, Oncology, Bone Marrow Transplant and Cellular Therapy at Seattle Children’s and director of the Ben Towne Center for Childhood Cancer Research at Seattle Children’s Research Institute. “It’s a new paradigm, and it shows how Seattle Children’s is at the forefront of improving the patient experience.”